Participant flow16

How many started, completed or left each group, period by period.

1 to 16 of 16

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo: IPs	731
Overall Study	STARTED	Baloxavir Marboxil: IPs	726
Overall Study	STARTED	Placebo: HHCs	1,336
Overall Study	STARTED	Baloxavir Marboxil: HHCs	1,345
Overall Study	Treated	Placebo: IPs	726
Overall Study	Treated	Baloxavir Marboxil: IPs	723
Overall Study	Treated	Placebo: HHCs	0
Overall Study	Treated	Baloxavir Marboxil: HHCs	0
Overall Study	COMPLETED	Placebo: IPs	699
Overall Study	COMPLETED	Baloxavir Marboxil: IPs	688
Overall Study	COMPLETED	Placebo: HHCs	1,300
Overall Study	COMPLETED	Baloxavir Marboxil: HHCs	1,305
Overall Study	NOT COMPLETED	Placebo: IPs	32
Overall Study	NOT COMPLETED	Baloxavir Marboxil: IPs	38
Overall Study	NOT COMPLETED	Placebo: HHCs	36
Overall Study	NOT COMPLETED	Baloxavir Marboxil: HHCs	40

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03969212/flow